Print Page     Close Window     

S-8 POS
CIPHER PHARMACEUTICALS INC filed this Form S-8 POS on 12/21/2016
Entire Document
 

 

As filed with the Securities and Exchange Commission on December 20, 2016

Registration No. 333-205112

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

CIPHER PHARMACEUTICALS INC.

(Exact name of registrant as specified in its charter)

 

Ontario, Canada

 

Not Applicable

(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)

 

2345 Argentia Road, Suite 100A

Mississauga, Ontario

L5N 8K4

(905) 602-5840

 

(Address of Principal Executive Offices)

 

Cipher Pharmaceuticals Inc. Stock Option Plan

(Full title of the plan)

 

CT Corporation

111 Eighth Avenue, 13th Floor

New York, New York 10011

(Name and address of agent for service)

 

(212) 590-9331

(Telephone number, including area code, of agent for service)

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

 

             
Large accelerated filer  o   Accelerated filer o   Non-accelerated filer þ   Smaller reporting company o
        (Do not check if a smaller reporting company)